Exchange: NASDAQ·Updated 04:41 AM EDT
STOK logo

STOK Stoke Therapeutics Inc

$30.30
$0.31
(1.03%)
Pre-Market
Prev Close $29.99
EarningsNov 3
Mkt Cap$1.97B
Vol361.00

About STOK

Stoke Therapeutics, Inc. is a biotechnology company, which engages in the research and development of treatments for genetic diseases. It offers a wide range of relevant tissues including the central nervous system, eye, kidney, and liver. The company was founded by Isabel Aznarez and Adrian R. Krainer in June 2014 and is headquartered in Bedford, MA.
46

Neutral Sentiment

How do you feel about STOK?

Advertisement|Remove ads.